N. SOYER And E. KAYA, "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis," 4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM , Rodos, Greece, pp.94-95, 2017
SOYER, N. And KAYA, E. 2017. Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis. 4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM , (Rodos, Greece), 94-95.
SOYER, N., & KAYA, E., (2017). Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis . 4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM (pp.94-95). Rodos, Greece
SOYER, NUR, And EMİN KAYA. "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis," 4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM, Rodos, Greece, 2017
SOYER, NUR And KAYA, EMİN. "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis." 4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM , Rodos, Greece, pp.94-95, 2017
SOYER, N. And KAYA, E. (2017) . "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis." 4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM , Rodos, Greece, pp.94-95.
@conferencepaper{conferencepaper, author={NUR SOYER And author={EMİN KAYA}, title={Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis}, congress name={4th AEGAN HEMATOLOGY ONCOLOGY SYMPOSIUM}, city={Rodos}, country={Greece}, year={2017}, pages={94-95} }